Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald”) and Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF)
(OTC:VFFIF) today announced that their 50/50 joint venture for
large-scale, low-cost, high-quality cannabis production, Pure Sunfarms,
received from Health Canada an amendment to its cultivation license for
its Delta 3 greenhouse in Delta, BC. This amendment permits Pure
Sunfarms to substantially expand its cannabis production to 225,000
square feet of the 1.1-million square foot Delta 3 production facility.
In
mid-May, Pure Sunfarms initiated commercial-scale production on 130,000
square feet at the Delta 3 greenhouse, which is now fully utilized,
with harvesting expected to begin in August. Planting in the
newly-licensed area will commence this week and is expected to be
completed by the end of July. Pure Sunfarms expects to have the full 1.1
million square foot Delta 3 facility, one of the single largest
cannabis growing facilities in the world, converted to cannabis
production by year end.
The
technologically-advanced Delta 3 greenhouse design is based on decades
of large-scale, low-cost agricultural production experience and
extensive cannabis expertise, resulting in a state-of-the-art facility
with 17 grow rooms optimized for year-round harvesting (more than 85
harvests annually) and an automated process line encompassing
harvesting, trimming, drying and packaging. The greenhouse is designed
to cultivate more than 200,000 cannabis plants concurrently.
“We
are thrilled to expand Pure Sunfarms’ production area to 225,000 square
feet,” said Michael DeGiglio, Director, Pure Sunfarms and CEO of
Village Farms. “Leveraging Village Farms’ deep experience designing
greenhouse operations globally for high-value crops, Pure Sunfarms has
developed the Delta 3 greenhouse to optimize operating conditions for
the highest quality and yield with continuous year-round harvesting. We
are not surprised to see our first commercial-scale crop thriving in
this environment and remain firmly on track for our production targets
in 2018 and beyond.”
“The Delta 3 production
facility is maturing at an outstanding pace thanks to our senior
cultivation, financial, and operational teams. We are making great
strides to achieve large-volume, high-quality, low-cost cannabis
production and anticipate receiving our sales license before the onset
of recreational sales on October 17th,” said Chris Wagner, Director,
Pure Sunfarms, and CEO of Emerald Health Therapeutics. “With the
Canadian government’s historic legalization of adult-use cannabis, we
are focused on meeting the needs of both medical and recreational
consumers in this new era of cannabis regulation.
About Village Farms International, Inc.
Village
Farms International, Inc. is one of the largest and longest-operating
vertically integrated greenhouse growers in North America and the only
publicly traded greenhouse produce company in Canada. With more than 750
years of accumulated master grower experience coupled with advanced
proprietary technology and environmentally sustainable growing
practices, Village Farms is highly resource efficient. Village Farms
produces and distributes fresh, premium-quality produce with consistency
365-days a year to national grocers in the U.S. and Canada from its
large-scale Controlled Environment Agriculture (CEA) greenhouses in
British Columbia and Texas, as well as from its partner greenhouses in
BC, Ontario, and Mexico.
About Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics (TSX-V:EMH) (OTCQX:EMHTF) (Frankfurt:TBD)
is a Licensed Producer under Canada’s Access to Cannabis for Medical
Purposes Regulations and produces and sells dried cannabis and cannabis
oil for medical purposes. Emerald is preparing to serve the fully
legalized Canadian adult-use cannabis market starting October 17, 2018.
Emerald owns 50% of Pure Sunfarms, which is converting a licensed
existing 1.1 million square foot greenhouse in Delta, BC and is now in
commercial production. It owns Agro-Biotech, a Québec-based licensed
cannabis grower with a 75,000 square foot indoor facility and is
planning to add a 500,000 square foot greenhouse in Metro Vancouver.
Emerald’s team is highly experienced in life sciences, product
development, large-scale agri-business, and marketing, and is focused on
developing value-added cannabis-based products with potential wellness
and medical benefits. Emerald is part of the Emerald Health group,
which is broadly focused on developing pharmaceutical, botanical, and
nutraceutical products that may provide wellness and medical benefits by
interacting with the human body’s endocannabinoid system.
No comments:
Post a Comment